A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unitPierre‐François Laterre, Bruno François, Miguel Sánchez García et al.|BMC Pulmonary Medicine|2020Cited by 23
The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trialPierre‐François Laterre, Bruno François, Kathy-Ann Cadogan et al.|Journal of Critical Care|2023Cited by 11
Pathogen-specific host response in critically ill patients with blood stream infections: a nested case–control studyJoe M. Butler, Tom van der Poll, Hessel Peters‐Sengers et al.|EBioMedicine|2025Cited by 8
Effect of mesenchymal stem cells on the host response in severe community-acquired pneumoniaTom D. Y. Reijnders, Tom van der Poll, Pierre-François Laterre et al.|Thorax|2024Cited by 7